Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-11T07:14:23.106Z Has data issue: false hasContentIssue false
  • English
  • Français

Defining failure after parathyroidectomy for primary hyperparathyroidism: case series

Published online by Cambridge University Press:  04 January 2011

S D Charlett ,
M Aye ,
S L Atkin  and
R J A England
S D Charlett*
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Hull Royal Infirmary, UK
M Aye
Affiliation:
Department of Endocrinology, Hull Royal Infirmary, UK
S L Atkin
Affiliation:
Department of Endocrinology, Hull Royal Infirmary, UK
R J A England
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Hull Royal Infirmary, UK
*
Address for correspondence: Mr S D Charlett, C/O Secretary to Mr England Department of Otolaryngology, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK E-mail: sdcharlett@doctors.org.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To identify the cause of operative failure in patients who have undergone parathyroid surgery for primary hyperparathyroidism.

Design:

Retrospective case review.

Participants:

Patients who had undergone a primary procedure for primary hyperparathyroidism between July 2003 and December 2007. Cases with incomplete post-operative serum calcium data were excluded.

Main outcome measure:

Operative failure was defined as failure to achieve normalisation of serum adjusted calcium levels post-operatively.

Results:

A total of 220 primary procedures were conducted over 4.5 years. Data were not available for 16 patients. Thirteen procedures (6.4 per cent) were considered failures, and these cases were individually reviewed and classified according to the reason for failure.

Conclusion:

Establishing the cause of failure following surgery for primary hyperparathyroidism can be a complex task. In some instances, diagnostic uncertainty remains despite detailed biochemical and radiological assessment. This paper outlines our approach to maximising the cure rate at primary surgery.

Keywords

Parathyroid HormonePrimary HyperparathyroidismHypercalcaemiaParathyroid AdenomaParathyroidectomy
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 125 , Issue 4 , April 2011 , pp. 394 - 398
Copyright
Copyright © JLO (1984) Limited 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Adami, S, Marcocci, C, Gatti, D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17(suppl 2):N18–23Google ScholarPubMed
2Watkinson, JC, Gaze, MN, Wilson, JA. Tumours of the thyroid and parathyroid glands. In: Watkinson, JC, Gaze, MN, Wilson, JA. Stell and Maran's Head and Neck Surgery, 4th edn.oxford: Butterworth Heinemann, 2000;459–85Google Scholar
3Carty, SE, Roberts, MM, Virji, MA, Haywood, L, Yim, JH. Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 2002;132:1086–92CrossRefGoogle ScholarPubMed
4Yen, TW, Wilson, SD, Krzywda, EA, Sugg, SL. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 2006;140:665–72CrossRefGoogle ScholarPubMed
5Shindo, ML, Rosenthal, JM. Minimal access parathyroidectomy using the focused lateral approach: technique, indication, and results. Arch Otolaryngol Head Neck Surg 2007;133:1227–34CrossRefGoogle Scholar
6Hinnie, J, Bell, E, McKillop, E, Gallacher, S. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 2001;68:216–18CrossRefGoogle ScholarPubMed
7Fuleihan, Gel-H. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 2002;17(suppl 2):N51–6Google ScholarPubMed
8Lyons, TJ, Crookes, PF, Postlethwaite, W, Sheridan, B, Brown, RC, Atkinson, AB. Familial hypocalciuric hypercalcaemia as a differential diagnosis of hyperparathyroidism: studies in a large kindred and a review of surgical experience in the condition. Br J Surg 1986;73:188–92CrossRefGoogle Scholar
9Allendorf, J, DiGorgi, M, Spanknebel, K, Inabnet, W, Chabot, J, Logerfo, P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg 2007;31:2075–80CrossRefGoogle ScholarPubMed
10Miura, D, Wada, N, Arici, C, Morita, E, Duh, QY, Clark, OH. Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy? World J Surg 2002;26:926–30CrossRefGoogle ScholarPubMed
11Westerdahl, J, Bergenfelz, A. Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation. Arch Surg 2006;141:589–94CrossRefGoogle ScholarPubMed
12Westerdahl, J, Lindblom, P, Bergenfelz, A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 2002;137:186–90CrossRefGoogle ScholarPubMed
13Chiu, B, Sturgeon, C, Angelos, P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? Arch Surg 2006;141:483–8CrossRefGoogle ScholarPubMed
14Dhillon, KS, Cohan, P, Darwin, C, Van Herle, A, Chopra, IJ. Elevated serum parathyroid hormone concentration in eucalcemic patients after parathyroidectomy for primary hyperparathyroidism and its relationship to vitamin D profile. Metabolism 2004;53:1101–6CrossRefGoogle ScholarPubMed
15Solorzano, CC, Mendez, W, Lew, JI, Rodgers, SE, Montano, R, Carneiro-Pla, DM et al. Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism. Arch Surg 2008;143:659–63CrossRefGoogle ScholarPubMed